[Anti-VEGF inhibitors and their role in the treatment of diabetic macular oedema].

Kakkassery, V

[Anti-VEGF inhibitors and their role in the treatment of diabetic macular oedema]. [electronic resource] - Klinische Monatsblatter fur Augenheilkunde Sep 2010 - 701-11 p. digital

Publication Type: Journal Article; Review

1439-3999

10.1055/s-0029-1245718 doi


Angiogenesis Inhibitors--administration & dosage
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized
Aptamers, Nucleotide--administration & dosage
Bevacizumab
Blood-Retinal Barrier--drug effects
Capillary Permeability--drug effects
Clinical Trials as Topic
Combined Modality Therapy
Diabetic Retinopathy--classification
Fluorescein Angiography
Humans
Intravitreal Injections
Laser Coagulation--adverse effects
Macular Edema--classification
Middle Aged
Off-Label Use
Ranibizumab
Receptors, Vascular Endothelial Growth Factor
Recombinant Fusion Proteins--administration & dosage
Retinoscopy
Triamcinolone--administration & dosage
Vascular Endothelial Growth Factor A--antagonists & inhibitors